In a TAC mouse model, exogenous miRNA-148a inhibited the expression of glycoprotein 130 (GP130) which in turn suppressed the phosphorylation of STAT3 and the expression of cardiac remodeling related genes, leading to improved ventricular dilatation and heart failure [23]. The gene discussed is STAT3; the disease is Vascular dilatation.